Renaissance Technologies - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 38 filers reported holding LIANBIO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of LIANBIO
ValueSharesWeighting
Q3 2023$421
-40.1%
282,602
-8.4%
0.00%0.0%
Q2 2023$703
+21.0%
308,500
+4.2%
0.00%0.0%
Q1 2023$581
+21.8%
296,200
+1.9%
0.00%0.0%
Q4 2022$477
-99.9%
290,622
-7.7%
0.00%0.0%
Q3 2022$630,000
+377.3%
315,000
+417.2%
0.00%
Q2 2022$132,000
-2.9%
60,900
+66.7%
0.00%
Q1 2022$136,00036,5240.00%
Other shareholders
LIANBIO shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 112,639,920$693,862,0005.35%
Vida Ventures Advisors, LLC 2,282,084$14,058,0005.26%
VR Adviser, LLC 5,378,341$33,131,0004.53%
SCHF (GPE), LLC 937,500$5,775,0001.04%
RA Capital Management 7,655,015$47,155,0000.83%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$20,415,0000.61%
Logos Global Management LP 412,837$2,543,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,782,747$10,982,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 275,007$1,662,0000.18%
Affinity Asset Advisors, LLC 72,406$446,0000.16%
View complete list of LIANBIO shareholders